abstract |
A method for increasing the expression of SIRT1 mRNA and/or decreasing the expression of SOCS3 mRNA, and especially for regulating blood glucose levels in a subject in need thereof is provided. The method comprises administering to the subject an effective amount of an active component selected from the group consisting of a compound of formula (I), a pharmaceutically acceptable salt of the compound of formula (I), and combinations thereof: n n n n n n n n n n wherein X is H or C1-C3 alkyl; one of Y and Z is n n n n n n n n n n and the other one is H, OH or n n n n n n n n n n wherein when Y is n n n n n n n n n n Z is n n n n n n n n n n R1 to R13 are independently H or OH, and wherein, R1 to R3 are not simultaneously H; R8 and R9 are not simultaneously H. |